- Home
- QNCX vs WHF Comparison
QNCX vs WHF Comparison
Compare QNCX & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- WHF
- Stock Information
- Founded
- QNCX 2012
- WHF 2011
- Country
- QNCX United States
- WHF United States
- Employees
- QNCX 36
- WHF N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- WHF Finance Companies
- Sector
- QNCX Health Care
- WHF Finance
- Exchange
- QNCX Nasdaq
- WHF Nasdaq
- Market Cap
- QNCX 139.2M
- WHF 162.2M
- IPO Year
- QNCX 2019
- WHF 2012
- Fundamental
- Price
- QNCX $2.68
- WHF $7.21
- Analyst Decision
- QNCX Strong Buy
- WHF Sell
- Analyst Count
- QNCX 4
- WHF 2
- Target Price
- QNCX $7.75
- WHF $7.75
- AVG Volume (30 Days)
- QNCX 551.1K
- WHF 162.1K
- Earning Date
- QNCX 11-12-2025
- WHF 11-10-2025
- Dividend Yield
- QNCX N/A
- WHF 24.79%
- EPS Growth
- QNCX N/A
- WHF N/A
- EPS
- QNCX N/A
- WHF 0.42
- Revenue
- QNCX N/A
- WHF $76,339,000.00
- Revenue This Year
- QNCX N/A
- WHF N/A
- Revenue Next Year
- QNCX N/A
- WHF N/A
- P/E Ratio
- QNCX N/A
- WHF $16.97
- Revenue Growth
- QNCX N/A
- WHF N/A
- 52 Week Low
- QNCX $0.72
- WHF $6.39
- 52 Week High
- QNCX $2.85
- WHF $11.31
- Technical
- Relative Strength Index (RSI)
- QNCX 83.72
- WHF 51.21
- Support Level
- QNCX $1.61
- WHF $7.01
- Resistance Level
- QNCX $1.84
- WHF $7.34
- Average True Range (ATR)
- QNCX 0.21
- WHF 0.24
- MACD
- QNCX 0.10
- WHF 0.03
- Stochastic Oscillator
- QNCX 87.94
- WHF 81.63
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.